Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-24-000023
Filing Date
2024-11-07
Accepted
2024-11-07 16:35:52
Documents
94
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 2887314
2 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 10928
3 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 10734
4 EX-32.1 tmb-20240930xex32d1.htm EX-32.1 5944
5 EX-32.2 tmb-20240930xex32d2.htm EX-32.2 6139
  Complete submission text file 0001070081-24-000023.txt   14462888

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240930.xsd EX-101.SCH 88330
7 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 82505
8 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 429357
9 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 823035
10 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 655869
97 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 3123495
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 241436462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)